ArticleDigestive diseases and sciences2025
LeLISA: A New Lectin-Based Immunoassay for Evaluation of Mucinous and Serous Content in Pancreatic Cystic Neoplasms.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe discrimination of mucinous from serous pancreatic cysts and pseudocysts is an important clinical issue. We aimed to investigate the possibility of using our LeLISA test for distinguishing between different types of pancreatic cysts. MATERIALS AND
methodsThe LeLISA is a special type of enzyme-linked immunosorbent assay (ELISA), where a lectin (Le) replaces the catching antibody. Eight different randomly selected lectins were used for coating microwells and subsequently incubated with pancreatic cyst fluids collected via endoscopic ultrasound fine needle aspiration from patients with mucinous cysts, serous cysts, and pseudocysts, 10 patients in each group. The binding of Muc/Cp to lectins was demonstrated by the method, where cyst fluids were incubated in microwells coated with different types of lectins followed by enzyme (Horseradish peroxidase) labeled monoclonal anti-Cp.
resultsMuc/Cp in cyst fluids was bound to several of the 8 lectins tested, in particular to Galanthus nivalis, Agaricus blazei Murill, and Phaseolus vulgaris. This was especially noticed for fluids from mucin-producing cysts. The fluid from the serous cysts had a lower optical density than the other cysts (p < 0.0001).
conclusionsThe LeLISA method for differentiation of pancreatic cyst content shows promising results, in particular for the detection of content in serous cysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.